Rasmussen's syndrome, an autoimmune disease;Síndrome de Rasmussen: Una enfermedad autoinmune

Anales de Pediatria

Volumn 59, Issue 2, 2003, Pages 187-189

  Carrillo Herranz, A ^a   Sanchez Perez I ^a   Aparicio Meix, J M ^a   Lozano Gimenez C ^a   Roy Arino G ^a   Villar Gimerans, L M ^a   Sanchez Munoz L ^a  

^a HOSPITAL RAMÓN Y CAJAL   (Spain)

Author keywords

Autoimmunity; Encephalitis; Epilepsia partialis continua; Epilepsy; Glutamic acid; Immunoglobulins; Rasmussen

Indexed keywords

GLUTAMATE DECARBOXYLASE ANTIBODY; GLUTAMATE RECEPTOR; GLUTAMATE RECEPTOR 3 ANTIBODY; IMMUNOGLOBULIN; IMMUNOSUPPRESSIVE AGENT; RECEPTOR ANTIBODY; STEROID; UNCLASSIFIED DRUG;

APHASIA; ARTICLE; AUTOIMMUNE DISEASE; CASE REPORT; CLINICAL FEATURE; COGNITIVE DEFECT; DISEASE ASSOCIATION; EPILEPSY; HEMIPARESIS; HEMISPHERECTOMY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MALE; PATHOPHYSIOLOGY; PLASMAPHERESIS; PRESCHOOL CHILD; RASMUSSEN SYNDROME; TREATMENT OUTCOME; VIRUS INFECTION;

EID: 0141703201     PISSN: 16954033     EISSN: None     Source Type: Journal    
DOI: 10.1157/13050113     Document Type: Article

References (13)

1. Bien CG, Widman G, Urbach H, Sassen R, Kuczaty S, Wiestler OD, et al. The natural hitory of Rasmussen's encephalitis. Brain 2002;125:1751-9.
2. Caraballo R, Tenembau S, Cersósimo R, Pomata H, Medina C, Soprano AM, et al. Sindrome de Rasmussen. Rev Neurol 1998;26:978-83.
3. Villanueva VE, Serratosa JM. Evolución de las epilepsias catastróficas. Rev Neurol 2002;34:501-5.
4. Panayiotopoulos CP. Kozhevnikov-Rasmussen syndrome and the New Proposal on Classification. Epilepsia 2002;43:948-9.
5. Leach JP, Chadwick DW, Miles JB, Hart IK. Improvement in adult-onset Rasmussen's encephalitis with long-term inmunomodulatory therapy. Neurology 1999;52:738-42.
6. Palace J, Lang B. Epilepsy: An autoinmune disease? J Neurol Neurosurg Psychiatry 2000;69:711-4.
7. Whitney KD, Andrews PI, McNamara JO. Immunoglobulin G and complement inmunoreactivity in the crebral cortex of patients with Rasmussen's encephalitis. Neurology 1999;53:699-708
8. Bien CG, Bauer J, Deckwerth TL, Wiendl H, Deckert M, Wiestler OD, et al. Destruction of neurons by cytotoxic T cells: A new pathogenic mechanism in Rasmussen's encephalitis. Ann Neurol 2002;51:311-8.
9. Baranzini SE, Laxer K, Saketkhoo R, Elkins MK, Parent JM, Mantegazza R, et al. Analysis of antibody gene rearrangement, usage, and specificity in chronic focal encephalitis. Neurology 2002;58:709-16.
10. Bien CG, Urbach H, Deckert M, Schramm J, Wiestler OD, Lassmann H, et al. Diagnosis and staging of Rasmussen's encephalitis by serial MRI and histopathology. Neurology 2002;58:250-7.
11. Peltola J, Kulmala P, Isojärvi J, Saiz A, Latvala K, Palmio J, et al. Autoantibodies to glutamic acid decarboxylase in patients with therapy-resistant epilepsy. Neurology 2000;55:46-50.
12. Olson JA, Olson DM, Sandborg C, Alexander S, Buckingham B. Type 1 diabetes mellitus and epilepsia partialis continua in a 6-year-old boy with elevated anti-GAD65 antibodies. Pediatrics 2002;109:e50.
13. Giometto B, Nicolao P, Macucci M, Tavolato B, Foxon R, Bottazzo GF. Temporal-lobe epilepsy associated with glutamic-acid-decarboxylase autoantibodies. Lancet 1998;352:457.